ABSTRACT
Objective To examine the association between timing of ART initiation in HIV-infected women and placental histopathology.
Design A nested sub-study in a larger cohort of HIV-infected women which examined the association between ART status and birth outcomes.
Methods Placentas (n=130) were examined for histopathology from two ART groups: stable (n=53), who initiated ART before conception and initiating (n=77), who started ART during pregnancy (median [IQR] 15 weeks gestation [11-18]). Using binomial regression we quantified associations between ART initiation timing with placental histopathology and pregnancy outcomes.
Results One-third of all placentas were <10th percentile weight-for-gestation and there was no significant difference between ART groups. Placental diameter, thickness, cord insertion position and fetal-placental weight ratio were also similar by group. However, placentas from the stable group showed increased maternal vascular malperfusion (MVM) (39.6% vs 19.4%), and decreased weight (392g vs 422g, p=0.09). MVM risk was twice as high (RR 2.03 [95% CI: 1.16 - 3.57]; p=0.01) in the stable group; the increased risk remaining significant when adjusting for maternal age (RR 2.04 [95% CI: 1.12 - 3.72]; p=0.02). Furthermore, MVM was significantly associated with pre-term delivery (PTD) and low birth weight (LBW) (p=0.002 and p<0.0001, respectively).
Conclusion Preconception initiation of ART was associated with an increased MVM risk, and may contribute to placental dysfunction. The association between MVM with PTD and LBW suggests that a placenta-mediated mechanism likely links the putative association between long-term use of ART and adverse birth outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01 HD080385 (PIMS Prematurity Immunology in HIV-Infected Infants and their Infants Study) National Institute for Health Research (NIHR) (17/63/26) using UK Government aid to support global health research and by the Academy of Medical Sciences networking grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Cape Town, Faculty of Health Sciences Human Research Ethics Committee (UCT-HREC) project #739/2014 University of Southampton Faculty of Medicine Ethics Committee project # 12542 PIMS
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† Co-First Authors
Conflict of interest statement The authors report no conflict of interest.
Funding Support: The research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01 HD080385 (PIMS Prematurity Immunology in HIV-Infected Women and their Infants Study); also in part by the National Institute for Health Research (NIHR) (17/63/26) using UK Government aid to support global health research and by the Academy of Medical Sciences networking grant. The views expressed in this publication are those of the author(s) and not necessarily those of the NICH NIH, NIHR or the UK Department of Health and Social Care.
Data Availability
The data collected in this study will be available to external investigators interested in collaboration upon submission and approval of a data analysis plan. Requests for data available within PIMS or to submit a request for additional data collection should be submitted to M.Newell{at}soton.ac.uk and Landon.Myer{at}uct.ac.za and will be reviewed by the study steering committee
